12:00 AM
 | 
Sep 20, 1999
 |  BC Week In Review  |  Company News  |  Deals

Parexel, CEMAF deal

PRXL acquired CEMAF, which offers Phase I clinical research,...

Read the full 33 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >